Mario Gabelli's BHC Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 874,452 shares of Bausch Health Companies Inc. (BHC) worth $6.08 M, representing 0.06% of the portfolio. First purchased in 2017-Q4, this long-term strategic position has been held for 30 quarters.
Based on 13F filings, Mario Gabelli has maintained a strategic position in BHC, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2020, adding 571,103 shares. Largest reduction occurred in Q4 2022, reducing 332,910 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Bausch Health Companies (BHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bausch Health Companies (BHC) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -31,592 | Reduce 3.49% | 874,452 | $6.95 |
| Q3 2025 | -90,963 | Reduce 9.12% | 906,044 | $6.45 |
| Q2 2025 | -46,434 | Reduce 4.45% | 997,007 | $6.66 |
| Q1 2025 | -31,700 | Reduce 2.95% | 1.04 M | $6.47 |
| Q4 2024 | +12,874 | Add 1.21% | 1.08 M | $8.06 |
| Q3 2024 | -113,000 | Reduce 9.61% | 1.06 M | $8.16 |
| Q2 2024 | -76,702 | Reduce 6.13% | 1.18 M | $6.97 |
| Q1 2024 | -16,632 | Reduce 1.31% | 1.25 M | $10.61 |
| Q4 2023 | -109,874 | Reduce 7.97% | 1.27 M | $8.02 |
| Q3 2023 | -37,470 | Reduce 2.65% | 1.38 M | $8.22 |
| Q2 2023 | +38,700 | Add 2.81% | 1.42 M | $8.00 |
| Q1 2023 | +52,111 | Add 3.93% | 1.38 M | $8.10 |
| Q4 2022 | -332,910 | Reduce 20.08% | 1.33 M | $6.28 |
| Q3 2022 | +49,612 | Add 3.08% | 1.66 M | $6.89 |
| Q2 2022 | +45,838 | Add 2.93% | 1.61 M | $8.36 |
| Q1 2022 | +302,479 | Add 24.00% | 1.56 M | $22.85 |
| Q4 2021 | +344,913 | Add 37.69% | 1.26 M | $27.61 |
| Q3 2021 | +100,069 | Add 12.28% | 915,202 | $27.85 |
| Q2 2021 | +49,535 | Add 6.47% | 815,133 | $29.32 |
| Q1 2021 | -9,997 | Reduce 1.29% | 765,598 | $31.74 |
| Q4 2020 | +118,495 | Add 18.03% | 775,595 | $20.80 |
| Q3 2020 | +157,150 | Add 31.43% | 657,100 | $15.54 |
| Q2 2020 | -112,953 | Reduce 18.43% | 499,950 | $18.29 |
| Q1 2020 | +571,103 | Add 1366.28% | 612,903 | $15.50 |
| Q4 2019 | +600 | Add 1.46% | 41,800 | $29.93 |
| Q3 2019 | +10,000 | Add 32.05% | 41,200 | $21.84 |
| Q1 2019 | +31,200 | New Buy | 31,200 | $24.71 |
| Q1 2018 | -12,000 | Sold Out | 0 | $0.00 |
| Q4 2017 | +12,000 | New Buy | 12,000 | $20.75 |
Mario Gabelli's Bausch Health Companies Investment FAQs
Mario Gabelli first purchased Bausch Health Companies Inc. (BHC) in Q4 2017, acquiring 12,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Bausch Health Companies Inc. (BHC) for 30 quarters since Q4 2017.
Mario Gabelli's largest addition to Bausch Health Companies Inc. (BHC) was in Q1 2020, adding 612,903 shares worth $9.5 M.
According to the latest 13F filing for Q4 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 874,452 shares of Bausch Health Companies Inc. (BHC), valued at approximately $6.08 M.
As of the Q4 2025 filing, Bausch Health Companies Inc. (BHC) represents approximately 0.06% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in Bausch Health Companies Inc. (BHC) was 1,658,044 shares, as reported at the end of Q3 2022.